APA (7th ed.) Citation

MA, B., BT, V., Y, L., R, G., AH, D., D, M., . . . VA, M. (2024). Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: A phase 2 trial. Research square. https://doi.org/10.21203/rs.3.rs-4849400/v1

Chicago Style (17th ed.) Citation

MA, Bilen, et al. "Neoadjuvant Cabozantinib Restores CD8+ T Cells in Patients with Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma: A Phase 2 Trial." Research Square 2024. https://doi.org/10.21203/rs.3.rs-4849400/v1.

MLA (9th ed.) Citation

MA, Bilen, et al. "Neoadjuvant Cabozantinib Restores CD8+ T Cells in Patients with Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma: A Phase 2 Trial." Research Square, 2024, https://doi.org/10.21203/rs.3.rs-4849400/v1.